XSHE000504
Market cap364mUSD
Jan 07, Last price
8.10CNY
1D
4.52%
1Q
-2.76%
Jan 2017
-51.12%
Name
Hunan CCID-Media Investments Co Ltd
Chart & Performance
Profile
NanHua Bio-medicine Co., Ltd. provides stem and immune cell storage, noninvasive genetic testing, and biological research and technical services. The company is based in Changsha, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 136,791 -31.72% | 200,345 27.92% | |||||||
Cost of revenue | 109,493 | 156,700 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 27,298 | 43,645 | |||||||
NOPBT Margin | 19.96% | 21.79% | |||||||
Operating Taxes | 2,070 | 8,202 | |||||||
Tax Rate | 7.58% | 18.79% | |||||||
NOPAT | 25,228 | 35,443 | |||||||
Net income | (28,173) | ||||||||
Dividends | (2,288) | ||||||||
Dividend yield | 0.06% | ||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 28,117 | 65,896 | |||||||
Long-term debt | 26,005 | 29,577 | |||||||
Deferred revenue | 1,059 | 1,830 | |||||||
Other long-term liabilities | 1,000 | ||||||||
Net debt | (445,105) | (128,159) | |||||||
Cash flow | |||||||||
Cash from operating activities | 36,277 | 166,381 | |||||||
CAPEX | (5,918) | ||||||||
Cash from investing activities | 12,753 | ||||||||
Cash from financing activities | 226,633 | ||||||||
FCF | 33,101 | 35,364 | |||||||
Balance | |||||||||
Cash | 495,529 | 219,833 | |||||||
Long term investments | 3,697 | 3,799 | |||||||
Excess cash | 492,387 | 213,615 | |||||||
Stockholders' equity | (108,646) | 422,386 | |||||||
Invested Capital | 455,498 | (59,489) | |||||||
ROIC | 12.74% | ||||||||
ROCE | 7.86% | 28.24% | |||||||
EV | |||||||||
Common stock shares outstanding | 313,029 | 311,574 | |||||||
Price | 11.60 -0.34% | 11.64 -37.42% | |||||||
Market cap | 3,631,138 0.12% | 3,626,720 -37.42% | |||||||
EV | 3,233,766 | 3,564,674 | |||||||
EBITDA | 42,792 | 49,858 | |||||||
EV/EBITDA | 75.57 | 71.50 | |||||||
Interest | 11,070 | 11,868 | |||||||
Interest/NOPBT | 40.55% | 27.19% |